GB0125093D0 - Multimeric proteins - Google Patents

Multimeric proteins

Info

Publication number
GB0125093D0
GB0125093D0 GBGB0125093.5A GB0125093A GB0125093D0 GB 0125093 D0 GB0125093 D0 GB 0125093D0 GB 0125093 A GB0125093 A GB 0125093A GB 0125093 D0 GB0125093 D0 GB 0125093D0
Authority
GB
United Kingdom
Prior art keywords
multimeric proteins
multimeric
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0125093.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southampton
Original Assignee
University of Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southampton filed Critical University of Southampton
Priority to GBGB0125093.5A priority Critical patent/GB0125093D0/en
Publication of GB0125093D0 publication Critical patent/GB0125093D0/en
Priority to PCT/GB2002/004729 priority patent/WO2003033028A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB0125093.5A 2001-10-18 2001-10-18 Multimeric proteins Ceased GB0125093D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0125093.5A GB0125093D0 (en) 2001-10-18 2001-10-18 Multimeric proteins
PCT/GB2002/004729 WO2003033028A2 (en) 2001-10-18 2002-10-18 Multimeric proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0125093.5A GB0125093D0 (en) 2001-10-18 2001-10-18 Multimeric proteins

Publications (1)

Publication Number Publication Date
GB0125093D0 true GB0125093D0 (en) 2001-12-12

Family

ID=9924133

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0125093.5A Ceased GB0125093D0 (en) 2001-10-18 2001-10-18 Multimeric proteins

Country Status (2)

Country Link
GB (1) GB0125093D0 (en)
WO (1) WO2003033028A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8302354U (en) 2003-09-17 2004-05-18 Orlando Rossi Jr Improvement introduced in phototherapeutic light source for treatment of hyperbilirubinemia
EP1955712A1 (en) * 2007-02-09 2008-08-13 Scil proteins GmbH Multimeric conjugate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3693671B2 (en) * 1991-03-15 2005-09-07 アムゲン インコーポレーテッド PEGylation of polypeptides
GB0015426D0 (en) * 2000-06-24 2000-08-16 Univ Southampton Method for generating soluble highly multimeric proteins
ES2747357T3 (en) * 2001-03-14 2020-03-10 Dako Denmark As MHC molecule constructs and their uses for diagnosis and therapy

Also Published As

Publication number Publication date
WO2003033028A2 (en) 2003-04-24
WO2003033028A3 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
GB0130228D0 (en) Protein
EP1365022A4 (en) Adiponectin-associated protein
GB0130557D0 (en) Proteins
GB0108079D0 (en) Protein
GB0130720D0 (en) Proteins
GB0125093D0 (en) Multimeric proteins
EP1373306A4 (en) Cytoskeletion-associated proteins
AU2002326909A8 (en) Neurotransmission-associated proteins
GB0130560D0 (en) Proteins
GB0130721D0 (en) Protein
GB0106318D0 (en) Protein
GB0024770D0 (en) Multimeric proteins
AU2002334199A1 (en) Multimeric proteins
GB0130742D0 (en) Proteins
GB0128596D0 (en) Proteins
GB0130384D0 (en) Proteins
GB0128487D0 (en) Proteins
GB0128374D0 (en) Proteins
GB0130718D0 (en) Proteins
GB0130719D0 (en) Proteins
GB0126787D0 (en) Proteins
GB0130722D0 (en) Proteins
GB0130739D0 (en) Proteins
GB0125514D0 (en) Proteins
GB0130743D0 (en) Proteins

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)